| Symbol | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ANTH | Chief Technology Officer | Oct 12, 2015 | Sale | $6.15 | 1,205 | 7,411 | 7,896 | Oct 13, 2015, 08:02 PM |
| ANTH | Chief Technology Officer | Mar 25, 2014 | Option Exercise | $3.30 | 2,783 | 9,184 | 6,601 | Mar 27, 2014, 09:57 PM |
| ANTH | Chief Technology Officer | Jun 30, 2013 | Option Exercise | $0.49 | 2,248 | 1,102 | 75,074 | Jul 02, 2013, 09:17 PM |
| ANTH | Chief Technology Officer | Jan 03, 2013 | Option Exercise | $0.69 | 3,409 | 2,352 | 31,812 | Jan 07, 2013, 09:18 PM |
| ANTH | Chief Technology Officer | Jun 30, 2012 | Option Exercise | $0.69 | 1,838 | 1,268 | 24,821 | Jul 03, 2012, 07:27 PM |
| ANTH | Chief Technology Officer | Mar 01, 2012 | Sale | $6.57 | 2,000 | 13,140 | 26,659 | Mar 05, 2012, 04:01 PM |
| ANTH | Chief Technology Officer | Feb 01, 2012 | Sale | $7.67 | 2,000 | 15,340 | 21,241 | Feb 03, 2012, 04:01 PM |
| ANTH | Chief Technology Officer | Jan 10, 2012 | Sale | $6.51 | 800 | 5,205 | 23,241 | Jan 12, 2012, 12:58 PM |
| ANTH | Chief Technology Officer | Jan 06, 2012 | Sale | $6.50 | 1,200 | 7,800 | 24,441 | Jan 10, 2012, 02:27 PM |
| ANTH | VP, Pharmaceutical R&D | Jun 30, 2011 | Option Exercise | $8.17 | 3,670 | 29,984 | 25,641 | Jul 05, 2011, 06:23 PM |
| ANTH | VP, Pharmaceutical R&D | Apr 13, 2011 | Option Exercise | $1.51 | 3,311 | 5,000 | 29,311 | Apr 14, 2011, 08:36 PM |
| ANTH | VP, Pharmaceutical R&D | Sep 24, 2010 | Buy | $4.20 | 1,000 | 4,200 | 26,000 | Sep 24, 2010, 09:22 PM |
| Symbol | Relationship | Date | Transaction | Value($) |
| ANTH | Chief Technology Officer | Oct 12, 2015 | Sale | 7,411 |
| ANTH | Chief Technology Officer | Mar 25, 2014 | Option Exercise | 9,184 |
| ANTH | Chief Technology Officer | Jun 30, 2013 | Option Exercise | 1,102 |
| ANTH | Chief Technology Officer | Jan 03, 2013 | Option Exercise | 2,352 |
| ANTH | Chief Technology Officer | Jun 30, 2012 | Option Exercise | 1,268 |
| ANTH | Chief Technology Officer | Mar 01, 2012 | Sale | 13,140 |
| ANTH | Chief Technology Officer | Feb 01, 2012 | Sale | 15,340 |
| ANTH | Chief Technology Officer | Jan 10, 2012 | Sale | 5,205 |
| ANTH | Chief Technology Officer | Jan 06, 2012 | Sale | 7,800 |
| ANTH | VP, Pharmaceutical R&D | Jun 30, 2011 | Option Exercise | 29,984 |
| ANTH | VP, Pharmaceutical R&D | Apr 13, 2011 | Option Exercise | 5,000 |
| ANTH | VP, Pharmaceutical R&D | Sep 24, 2010 | Buy | 4,200 |